Dopamine D2 and D3 receptors — Drug Target

All drugs that target Dopamine D2 and D3 receptors — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Dopamine agonist

Phase 3 pipeline (1)

• Requip PR · Rajesh Pahwa, MD · Dopamine agonist · Neurology
  Requip PR is a dopamine agonist that stimulates dopamine receptors in the brain to increase dopamine activity.